Low frequency stimulation of the nucleus tegmenti pedunculopontini increases cortical metabolism in Parkinsonian patients

European Journal of Neurology

Volumn 18, Issue 6, 2011, Pages 842-849

  Ceravolo, R ^a   Brusa, L ^b   Galati, S ^c   Volterrani, D ^a   Peppe, A ^d   Siciliano, G ^a   Pierantozzi, M ^c   Moschella, V ^c   Bonuccelli, U ^a   Stanzione, P ^c,d   Stefani, A ^c,d  

^a UNIVERSITY OF PISA   (Italy)

^b S EUGENIO HOSPITAL   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

^d IRCCS FONDAZIONE SANTA LUCIA   (Italy)

Author keywords

Deep brain stimulation; Executive functions; FDG PET; PPN

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

APTITUDE TEST; ARTICLE; BRAIN DEPTH STIMULATION; BRAIN METABOLISM; BRAIN REGION; CLINICAL ARTICLE; COGNITION; CORPUS STRIATUM; FRONTAL GYRUS; GLUCOSE UTILIZATION; HUMAN; INSULA; PARKINSON DISEASE; PEDUNCULOPONTINE TEGMENTAL NUCLEUS; POSITRON EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; PRIORITY JOURNAL; RECALL; STEREOTAXIC SURGERY; SUPRAMARGINAL GYRUS; TEMPORAL GYRUS;

CEREBELLUM; COGNITION DISORDERS; DEEP BRAIN STIMULATION; ENERGY METABOLISM; FEMALE; GLUCOSE; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; PEDUNCULOPONTINE TEGMENTAL NUCLEUS; POSITRON-EMISSION TOMOGRAPHY; STEREOTAXIC TECHNIQUES; TREATMENT OUTCOME;

EID: 79955721235     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2010.03254.x     Document Type: Article

References (43)

1. Rodriguez-Oroz MC, Obeso JA, Lang AE, et al. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4years follow-up. Brain 2005; 128: 2240-2249.
2. Woods SP, Fields JA, Tröster AI. Neuropsychological sequelae of subthalamic nucleus deep brain stimulation in Parkinson's disease: a critical review. Neuropsychol Rev 2002; 12: 111-126.
3. Witt K, Daniels C, Reiff J, et al. Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson's disease: a randomised, multicentre study. Lancet Neurol 2008; 7: 605-614.
4. Parsons TD, Rogers SA, Braaten AJ, Woods SP, Tröster AI. Cognitive sequelae of subthalamic nucleus deep brain stimulation in Parkinson's disease: a meta-analysis. Lancet Neurol 2006; 5: 578-588.
5. Smeding HM, Speelman JD, Koning-Haanstra M, et al. Neuropsychological effects of bilateral STN stimulation in Parkinson disease: a controlled study. Neurology 2006; 66: 1830-1836.
6. Brudzynski SM, Houghton PE, Brownlee RD, Mogenson GJ. Involvement of neuronal cell bodies of the mesencephalic locomotor region in the initiation of locomotor activity of freely behaving rats. Brain Res Bull 1986; 16: 377-381.
7. Garcia-Rill A, Houser CR, Skinner RD, Smith W, Woodward DJ. Locomotioninducing sites in the vicinity of the pedunculopontine nucleus. Brain Res Bull 1987; 18: 731-738.
8. Takakusaki K. Forebrain control of locomotor behaviors. Brain Res Rev 2008; 57: 192-1989.
9. Jenkinson N, Nandi D, Miall RC, Stein JF, Aziz TZ. Pedunculopontine nucleus stimulation improves akinesia in a Parkinsonian monkey. Neuroreport 2004; 15: 2621-2624.
10. Nandi D, Liu X, Winter JL, Aziz TZ, Stein JF. Deep brain stimulation of the pedunculopontine region in the normal non-human primate. J Clin Neurosci 2002; 9: 170-174.
11. Mena-Segovia J, Bolam JP, Magill PJ. Pedunculopontine nucleus and basal ganglia: distant relatives or part of the same family? Trends Neurosci 2004; 27: 585-588.
12. Papahill H, Lozano AM. The pedunculopontine nucleus and Parkinson's disease. Brain 2000; 123: 1767-1783.
13. Mazzone P, Lozano A, Stanzione P, et al. Implantation of human pedunculopontine nucleus: a safe and clinically relevant target in Parkinson's disease. Neuroreport 2005; 16: 1877-1881.
14. Plaha P, Gill SS. Bilateral deep brain stimulation of the pedunculopontine nucleus for Parkinson's disease. Neuroreport 2005; 16: 1883-1887.
15. Stefani A, Lozano AM, Peppe A, Stanzione P, Galati S, Tropepi D. Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson's disease. Brain 2007; 130: 1596-1607.
16. Mazzone P, Sposato S, Insola A, Di Lazzaro V, Scarnati E. Stereotactic surgery of nucleus tegmenti pedunculopontini. Br J Neurosurg 2008; 22: S33-S40.
17. Romigi A, Placidi F, Peppe A, et al. Pedunculopontine nucleus stimulation influences REM sleep in Parkinson's disease. Eur J Neurol 2008; 15: 64-65.
18. Costa A, Carlesimo GA, Caltagirone C, et al. Effects of deep brain stimulation of the peduncolopontine area on working memory tasks in patients with Parkinson's disease. Parkinsonism Relat Disord 2010; 16: 64-67.
19. Olszewski J, Baxter D. Cytoarchitecture of the Human Brain Stem. Basel: S. Karger, 1982.
20. Paxinos G, Huang XF. Atlas of the Human Brainstem. San Diego: Academic Press, 1995.
21. Schaltenbrand G, Wahren W. Atlas for Stereotaxy of the Human Brain. Stuttgart, New York: Thieme, 1977.
22. Ceravolo R, Borghetti D, Kiferle L, et al. CSF phosphorylated TAU protein levels correlate with cerebral glucose metabolism assessed with PET in Alzheimer's disease. Brain Res Bull 2008; 76: 80-84.
23. Langston JW, Widner H, Goetz GC, et al. Core assessment program for intracerebral transplantations (CAPIT). Mov Disord 1992; 7: 2-13.
24. Fahn S, Elton RL, Members of the UPDRS Development Committee. Unified Parkinson's disease rating scale. In: Fahn S, Marsden CD, Goldstein M, Calne DB, eds. Recent Developments in Parkinson's Disease. New York, NY: Macmillan, 1987: 153-163.
25. Strafella AP, Lozano AM, Ballanger B, Poon YY, Lang AE, Moro E. rCBF changes associated with PPN stimulation in a patient with Parkinson's disease: a PET study. Mov Disord 2008; 23: 1051-1054.
26. 2O PET study. Hum Brain Mapp 2009; 30: 3901-3909.
27. Asanuma K, Tang C, Ma Y, et al. Network modulation in the treatment of Parkinson's disease. Brain 2006; 129: 2667-2678.
28. Hilker R, Voges J, Thiel A, et al. Deep brain stimulation of the subthalamic nucleus versus levodopa challenge in Parkinson's disease: measuring the on- and off-conditions with FDGPET. J Neural Transm 2002; 109: 1257-1264.
29. Hilker R, Voges J, Weisenbach S, et al. Subthalamic nucleus stimulation restores glucose metabolism in associative and limbic cortices and in cerebellum: evidence from a FDG-PET study in advanced Parkinson's disease. J Cereb Blood Flow Metab 2004; 24: 7-16.
30. Kalbe E, Voges J, Weber T, et al. Frontal FDG-PET activity correlates with cognitive outcome after STN-DBS in Parkinson disease. Neurology 2009; 72: 42-49.
31. Zrinzo L, Zrinzo L, Tisch S, et al. Stereotactic localization of the human peduncolopontine nucleus: atlas-base coordinates and validation of a magnetic resonance imaging protocol for direct localization. Brain 2008; 131: 1588-1598.
32. Pierantozzi M, Palmieri MG, Galati S, et al. Pedunculopontine nucleus deep brain stimulation changes spinal cord excitability in Parkinson's disease patients. J Neural Transm 2008; 115: 731-735.
33. Zanini S, Moschella V, Stefani A, et al. Grammar improvement following deep brain stimulation of the subthalamic and the pedunculopontine nuclei in advanced parkinson's disease: a pilot study. Parkinsonism Relat Disord 2009; 15: 606-609.
34. Androulidakis AG, Mazzone P, Litvak V, et al. Oscillatory activity in the pedunculopontine area of patients with Parkinson's disease. Exp Neurol 2008; 211: 59-66.
35. Kozak R, Bowman EM, Latimer MP, Rostron CL, Winn P. Excitotoxic lesions of the pedunculopontine tegmental nucleus in rats impair performance on a test of sustained attention. Exp Brain Res 2005; 162: 257-264.
36. Winn P. How best to consider the structure and function of the pedunculopontine tegmental nucleus: evidence from animal studies. J Neurol Sci 2006; 248: 234-250.
37. Grace AA, Floresco SB, Goto Y, Lodge DJ. Regulation of firing of dopaminergic neurons and control of goal-directed behaviors. Trends Neurosci 2007; 30: 220-227.
38. Peppe A, Pierantozzi M, Bassi A, et al. Stimulation of the subthalamic nucleus compared with the globus pallidus internus in patients with Parkinson disease. J Neurosurg 2004; 101: 195-200.
39. Stefani A, Peppe A, Pierantozzi M, et al. Multi-target strategy for Parkinsonian patients:the role of deep brain stimulation in the centromedian-parafascicularis complex. Brain Res Bull 2009; 78: 113-118.
40. Bédard MA, el Massioui F, Malapani C, et al. Attentional deficits in Parkinson's disease: partial reversibility with naphtoxazine (SDZ NVI-085), a selective noradrenergic alpha 1 agonist. Clin Neuropharmacol 1998; 21: 108-117.
41. Chamberlain SR, Del Campo N, Dowson J, et al. Atomoxetine improved response inhibition in adults with attention deficit/hyperactivity disorder. Biol Psychiatry 2007; 6: 977-984.
42. Thobois S, Dominey P, Fraix V, et al. Effects of subthalamic nucleus stimulation on actual and imagined movement in Parkinson's disease: a PET study. J Neurol 2002; 249: 1689-1698.
43. Moro E, Hamani C, Poon YY, et al. Unilateral pedunculopontine stimulation improves falls in Parkinson's disease. Brain 2010; 133: 215-224.